Funded Startups in Turku
Among the 9 most recent funded Turku-area entries, the largest disclosed round is Algorithmiq’s $21M (2026-05-11), which sits well above the rest of the di…
Among the 9 most recent funded Turku-area entries, the largest disclosed round is Algorithmiq’s $21M (2026-05-11), which sits well above the rest of the disclosed amounts: aside from Takomo Golf Company’s $23M (2025-05-14), most other disclosed rounds cluster between $2M and $11M, with Medbase’s $100K (2022-02-15) the main low-end outlier.
The list also shows a tight temporal edge: 3 of 9 rounds fall in 2025–2026 (Takomo Golf Company on 2025-05-14, Algorithmiq on 2026-05-11, and Faron Pharmaceuticals on 2024-03-04), while another 3 land in mid-2023 to early-2024 (Videobot 2023-08-29, Comptek Solutions 2023-08-15, DelSiTech 2024-01-16). Sector mix clusters heavily around Biotechnology and Health Care: Biotechnology appears in 3 of 9 entries (Algorithmiq, Faron Pharmaceuticals, Brinter) and Health Care appears in 2 of 9 (Faron Pharmaceuticals, DelSiTech, Medbase).
Most recent rounds
9 shownRelated listings
Frequently asked
What stands out in the disclosed round sizes, and where do most amounts cluster?
Takomo Golf Company’s $23M (2025-05-14) and Algorithmiq’s $21M (2026-05-11) dwarf the rest of the disclosed amounts, while most other disclosed rounds sit in a $2M–$11M band (e.g., DelSiTech $11M on 2024-01-16; Comptek Solutions $9M on 2023-08-15; Videobot $2M on 2023-08-29). Medbase is the low-end outlier at $100K on 2022-02-15.
Are the most recent rounds concentrated in a short date window?
Yes. 2025–2026 account for 2 of 9 rounds in the table (Takomo Golf Company $23M on 2025-05-14 and Algorithmiq $21M on 2026-05-11), and the mid-2023 to early-2024 period adds another cluster (Comptek Solutions $9M on 2023-08-15; Videobot $2M on 2023-08-29; DelSiTech $11M on 2024-01-16).
Does the sector mix skew toward specific verticals in Turku?
Biotechnology is over-represented relative to the rest, appearing in 3 of 9 entries (Algorithmiq, Faron Pharmaceuticals, Brinter), while Health Care also shows up repeatedly across 3 of 9 entries including DelSiTech, Faron Pharmaceuticals, and Medbase. The remaining categories are represented by single entries (e.g., Hardware by Comptek Solutions, Sales and Marketing by Videobot, Commerce and Shopping by Takomo Golf Company).
How dominant is “Series Unknown” or “undisclosed” in these 9 rows?
“Series Unknown” is common, appearing in 3 of 9 entries (Algorithmiq on 2026-05-11; Takomo Golf Company on 2025-05-14; Faron Pharmaceuticals on 2024-03-04), and one additional entry is explicitly “undisclosed” (Grumblo on 2023-01-31). That leaves only 5 of 9 with a named stage (Seed, Series A, Private Equity, plus two Series A entries including Comptek Solutions and Grumblo has undisclosed amount).
Which stage mix shows up most, and does the amount range differ by stage?
Series A is the most frequent named stage, covering 2 of 9 entries (Comptek Solutions $9M on 2023-08-15 and Grumblo on 2023-01-31 with an undisclosed amount). Seed appears once (Videobot $2M on 2023-08-29), and Private Equity appears once (Medbase $100K on 2022-02-15), which aligns with the low-end disclosed amount seen in the table.
Are any entries clear outliers by amount or classification?
Yes. Medbase’s $100K (2022-02-15) is the smallest disclosed amount, far below the next-low disclosed entries like Videobot’s $2M (2023-08-29) and Brinter’s $2M (2021-06-10). On the high end, the $21M–$23M range (Algorithmiq $21M on 2026-05-11; Takomo Golf Company $23M on 2025-05-14) concentrates well above the rest of the disclosed amounts.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.